Back to top

Tyra Bioscience (TYRA) Gets a Buy from Oppenheimer

Oppenheimer analyst Matthew Biegler reiterated a Buy rating on Tyra Bioscience today and set a price target of $50.00. Biegler covers the Healthcar...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Tyra Biosciences, Inc. (TYRA)